SMBC Venture Capital

RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a specialized radiation therapy that uses nuclear reactions between neutrons and boron-10 to destroy cancer cells.

EX-Fusion is focused on developing and operating the world's first laser-powered commercial nuclear fusion reactor, aiming to provide a sustainable energy solution. The company specializes in the manufacture of continuous plasma generators and is involved in laser-plasma research, offering technology and R&D support for fusion systems. By advancing the practical application of laser fusion, EX-Fusion seeks to overcome the challenges often faced by government-funded fusion research, which can be hindered by shifting political priorities and budget constraints. Through its innovative approach, EX-Fusion aims to contribute significantly to the field of clean energy.

Founded in Kyoto, Japan in 2019, Kyoto Fusioneering is a privately funded technology company focused on developing advanced technologies for commercial fusion reactors. Their work includes gyrotron systems, tritium fuel cycle technologies, and breeding blankets for tritium production and power generation. The company aims to accelerate the realization of fusion energy as a viable, carbon-free power source.